Among the most dependable areas of healthcare investment stands the global Australia and New Zealand Immunoassay and Molecular Diagnostics market within the medical device industry, with the greatest transformative capacity for expansion and innovation. A modern healthcare setup reflects advances in the equipment to enable quick treatments and pinpoint accuracy in results. The global Australia...
According to a newly published market research report by 24LifeSciences, global Hepatitis B and C Diagnostics market was valued at USD 3.8 billion in 2024 and is projected to reach USD 5.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025-2031.
Hepatitis B diagnostic tests analyze blood samples for HBV antigens/antibodies (HBsAg, anti-HBc,...
Nucleic Acid Amplification Testing Industry Outlook:
Straits Research has introduced a detailed analytical study on the Nucleic Acid Amplification Testing Market, offering insights into market valuation, segmentation framework, and long-term growth trajectory. The publication delivers a structured overview of market drivers, constraints, technological advancements, and strategic...
The global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...
Among the most dependable areas of healthcare investment stands the global US Molecular Diagnostics market within the medical device industry, with the greatest transformative capacity for expansion and innovation. A modern healthcare setup reflects advances in the equipment to enable quick treatments and pinpoint accuracy in results. The global US Molecular...
The Tuberculosis Diagnosis and Treatment Market is witnessing substantial growth due to the increasing prevalence of tuberculosis (TB) worldwide, rising awareness regarding early disease detection, and growing investments in advanced diagnostic technologies. Governments, healthcare organizations, and pharmaceutical companies are intensifying efforts to control TB through improved screening...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt